组别(n) | 时间 | CRP (mg/L) | TNF-α (μg/L) | IL-6 (μg/L) | WBC (×109/L) | D-D (mg/L) | AMY (U/L) |
观察组(267) | 治疗前 | 23.17 ± 5.67 | 228.84 ± 28.96 | 112.40 ± 21.33 | 14.06 ± 4.22 | 3.72 ± 0.54 | 433.54 ± 26.82 |
| 治疗后 | 10.64 ± 4.25 | 43.67 ± 12.40 | 31.54 ± 9.52 | 8.30 ± 1.35 | 1.01 ± 0.13 | 109.35 ± 8.74 |
对照组(289) | 治疗前 | 22.49 ± 4.93 | 230.47 ± 29.71 | 110.84 ± 23.48 | 13.94 ± 3.92 | 3.80 ± 0.42 | 428.97 ± 37.70 |
| 治疗后 | 14.06 ± 3.55 | 170.25 ± 13.92 | 68.62 ± 10.91 | 11.47 ± 2.13 | 1.98 ± 0.33 | 115.35 ± 9.31 |
t1/P |
| 1.431/0.153 | 0.621/0.535 | 0.778/0.437 | 0.329/0.742 | 1.849/0.065 | 1.562/0.119 |
t2/P |
| 27.959/<0.001 | 92.937/<0.001 | 54.735/<0.001 | 20.555/<0.001 | 77.146/<0.001 | 181.717/<0.001 |
t3/P |
| 21.940/<0.001 | 29.021/<0.001 | 25.783/<0.001 | 8.754/<0.001 | 53.875/<0.001 | 127.696/<0.001 |
t4/P |
| 9.765/<0.001 | 107.360/<0.001 | 40.491/<0.001 | 19.876/<0.001 | 43.242/<0.001 | 7.429/<0.001 |